These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 19789239)
1. RGD-labeled USPIO inhibits adhesion and endocytotic activity of alpha v beta3-integrin-expressing glioma cells and only accumulates in the vascular tumor compartment. Kiessling F; Huppert J; Zhang C; Jayapaul J; Zwick S; Woenne EC; Mueller MM; Zentgraf H; Eisenhut M; Addadi Y; Neeman M; Semmler W Radiology; 2009 Nov; 253(2):462-9. PubMed ID: 19789239 [TBL] [Abstract][Full Text] [Related]
2. Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. Zhang C; Jugold M; Woenne EC; Lammers T; Morgenstern B; Mueller MM; Zentgraf H; Bock M; Eisenhut M; Semmler W; Kiessling F Cancer Res; 2007 Feb; 67(4):1555-62. PubMed ID: 17308094 [TBL] [Abstract][Full Text] [Related]
3. Noninvasively characterizing the different alphavbeta3 expression patterns in lung cancers with RGD-USPIO using a clinical 3.0T MR scanner. Jiang T; Zhang C; Zheng X; Xu X; Xie X; Liu H; Liu S Int J Nanomedicine; 2009; 4():241-9. PubMed ID: 20011241 [TBL] [Abstract][Full Text] [Related]
4. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression. Li ZB; Cai W; Cao Q; Chen K; Wu Z; He L; Chen X J Nucl Med; 2007 Jul; 48(7):1162-71. PubMed ID: 17574975 [TBL] [Abstract][Full Text] [Related]
5. Integrin α Li D; Dong C; Ma X; Zhao X Cancer Imaging; 2021 Jun; 21(1):44. PubMed ID: 34187570 [TBL] [Abstract][Full Text] [Related]
6. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner. Li X; Du X; Huo T; Liu X; Zhang S; Yuan F Acta Radiol; 2009 Jul; 50(6):583-94. PubMed ID: 19449236 [TBL] [Abstract][Full Text] [Related]
7. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848 [TBL] [Abstract][Full Text] [Related]
10. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in an orthotopic glioblastoma model. Hsu AR; Hou LC; Veeravagu A; Greve JM; Vogel H; Tse V; Chen X Mol Imaging Biol; 2006; 8(6):315-23. PubMed ID: 17053862 [TBL] [Abstract][Full Text] [Related]
11. Gadopentetate dimeglumine versus ultrasmall superparamagnetic iron oxide for dynamic contrast-enhanced MR imaging of tumor angiogenesis in human colon carcinoma in mice. de Lussanet QG; Backes WH; Griffioen AW; van Engelshoven JM; Beets-Tan RG Radiology; 2003 Nov; 229(2):429-38. PubMed ID: 14595147 [TBL] [Abstract][Full Text] [Related]
12. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts. Chen X; Conti PS; Moats RA Cancer Res; 2004 Nov; 64(21):8009-14. PubMed ID: 15520209 [TBL] [Abstract][Full Text] [Related]
13. [MRI monitoring ultra-small superparamagnetic iron oxide (USPIO) particle labeling C6 rat glioma cells]. Zhang GX; Li YJ; Zhang F; Zhao JL; Li KA; Hu YS Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):228-32. PubMed ID: 17425864 [TBL] [Abstract][Full Text] [Related]
14. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles. Lee HY; Li Z; Chen K; Hsu AR; Xu C; Xie J; Sun S; Chen X J Nucl Med; 2008 Aug; 49(8):1371-9. PubMed ID: 18632815 [TBL] [Abstract][Full Text] [Related]